PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Paediatrics and Adolescent Medicine, Hong Kong Children\'s Hospital, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Laboratory of Data Discovery for Health (D4H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2022.2050952
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 35254219
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35254219>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35254219>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all